4/26
12:00 pm
supn
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
4/24
04:05 pm
supn
Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
Medium
Report
Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
4/24
03:17 pm
supn
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
4/20
11:00 am
supn
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
4/18
11:30 am
supn
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
4/8
12:20 pm
supn
Supernus Pharmaceuticals Faces Second FDA Rejection For Investigational Device For Parkinson's Disease [Yahoo! Finance]
Low
Report
Supernus Pharmaceuticals Faces Second FDA Rejection For Investigational Device For Parkinson's Disease [Yahoo! Finance]
4/8
08:14 am
supn
Supernus Provides Regulatory Update for SPN-830 [Yahoo! Finance]
Medium
Report
Supernus Provides Regulatory Update for SPN-830 [Yahoo! Finance]
4/8
08:00 am
supn
Supernus Provides Regulatory Update for SPN-830
Low
Report
Supernus Provides Regulatory Update for SPN-830
2/27/2024
04:05 pm
supn
supernus pharmaceuticals, inc.
MISS
Report
1.3%
supernus pharmaceuticals, inc.
11/8/2023
04:05 pm
supn
supernus pharmaceuticals, inc.
MISS
Report
11.1%
supernus pharmaceuticals, inc.
8/8/2023
04:17 pm
supn
supernus pharmaceuticals, inc.
MISS
Report
-7.2%
supernus pharmaceuticals, inc.
5/9/2023
04:05 pm
supn
supernus pharmaceuticals, inc.
BEAT
Report
1.5%
supernus pharmaceuticals, inc.
4/24
04:09 pm
supn
Form 8-K SUPERNUS PHARMACEUTICALS For: Apr 24
Medium
Report
Form 8-K SUPERNUS PHARMACEUTICALS For: Apr 24
4/24
04:06 pm
supn
Form 8-K SUPERNUS PHARMACEUTICALS For: Apr 22
Medium
Report
Form 8-K SUPERNUS PHARMACEUTICALS For: Apr 22
4/8
08:04 am
supn
Form 8-K SUPERNUS PHARMACEUTICALS For: Apr 08
Medium
Report
Form 8-K SUPERNUS PHARMACEUTICALS For: Apr 08
3/25
05:00 pm
supn
Form 4 SUPERNUS PHARMACEUTICALS For: Mar 21 Filed by: Bhatt Padmanabh P.
Low
Report
Form 4 SUPERNUS PHARMACEUTICALS For: Mar 21 Filed by: Bhatt Padmanabh P.
3/22
05:01 pm
supn
Form 4 SUPERNUS PHARMACEUTICALS For: Mar 20 Filed by: Bhatt Padmanabh P.
Medium
Report
Form 4 SUPERNUS PHARMACEUTICALS For: Mar 20 Filed by: Bhatt Padmanabh P.
3/21
05:03 pm
supn
Form 4 SUPERNUS PHARMACEUTICALS For: Mar 19 Filed by: Bhatt Padmanabh P.
Low
Report
Form 4 SUPERNUS PHARMACEUTICALS For: Mar 19 Filed by: Bhatt Padmanabh P.
3/19
04:21 pm
supn
Form 144 SUPERNUS PHARMACEUTICALS Filed by: Bhatt Padmanabh P.
Low
Report
Form 144 SUPERNUS PHARMACEUTICALS Filed by: Bhatt Padmanabh P.
3/15
06:39 pm
supn
Form 4 SUPERNUS PHARMACEUTICALS For: Mar 13 Filed by: Bhatt Padmanabh P.
Medium
Report
Form 4 SUPERNUS PHARMACEUTICALS For: Mar 13 Filed by: Bhatt Padmanabh P.
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register